title: Single-cell nanotoxicity assays of superparamagnetic iron oxide nanoparticles.
abstract: Properly evaluating the nanotoxicity of nanoparticles involves much more than bulk-cell assays of cell death by necrosis. Cells exposed to nanoparticles may undergo repairable oxidative stress and DNA damage or be induced into apoptosis. Exposure to nanoparticles may cause the cells to alter their proliferation or differentiation or their cell-cell signaling with neighboring cells in a tissue. Nanoparticles are usually more toxic to some cell subpopulations than others, and toxicity often varies with cell cycle. All of these facts dictate that any nanotoxicity assay must be at the single-cell level and must try whenever feasible and reasonable to include many of these other factors. Focusing on one type of quantitative measure of nanotoxicity, we describe flow and scanning image cytometry approaches to measuring nanotoxicity at the single-cell level by using a commonly used assay for distinguishing between necrotic and apoptotic causes of cell death by one type of nanoparticle. Flow cytometry is fast and quantitative, provided that the cells can be prepared into a single-cell suspension for analysis. But when cells cannot be put into suspension without altering nanotoxicity results, or if morphology, attachment, and stain location are important, a scanning image cytometry approach must be used. Both methods are described with application to a particular type of nanoparticle, a superparamagnetic iron oxide nanoparticle (SPION), as an example of how these assays may be applied to the more general problem of determining the effects of nanomaterial exposure to living cells.
authors.affiliation: Weldon School of Biomedical Engineering, Purdue University, West Lafayette, IN, USA.
authors.forename: Trisha
authors.initials: T
authors.lastname: Eustaquio
authors.forename: James F
authors.initials: JF
authors.lastname: Leary
mesh_terms: D017304:Annexin A5 / Q000378:metabolism; D017209:Apoptosis / Q000187:drug effects; D001562:Benzimidazoles / Q000378:metabolism; D003911:Dextrans / Q000633:toxicity*; D005434:Flow Cytometry; D005453:Fluorescence; D006801:Humans; D061986:MCF-7 Cells; D058185:Magnetite Nanoparticles / Q000633:toxicity*; D053758:Nanoparticles / Q000633:toxicity*; D009336:Necrosis; D011419:Propidium / Q000378:metabolism; D018675:Toxicity Tests / Q000379:methods*
chemical_list: D017304:Annexin A5; D001562:Benzimidazoles; D003911:Dextrans; D058185:Magnetite Nanoparticles; D011419:Propidium; C065507:ferumoxides; C017807:bisbenzimide ethoxide trihydrochloride